Antibodies to diphtheria, tetanus and pertussis in infants before and after immunization with DTP (Triple Antigen) vaccine

Journal of Paediatrics and Child Health

Volumn 32, Issue 5, 1996, Pages 378-381

  Stewart, T A ^a   Nolan, T M ^a,d,e   Hogg, G ^b,f   Mcewen, J ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Women's Children's Hlth Care Netwk   (Australia)

^c Drug Safety and Evaluation Branch   (Australia)

^d ROYAL CHILDREN'S HOSPITAL   (Australia)

^e Clin Epidemiol and Biostatist U   (Australia)

^f Melbourne Diagnostic Unit   (Australia)

Author keywords

Child; Diphtheria; DTP; Immunization; Pertussis; Seroprevalence; Tetanus

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE;

ARTICLE; AUSTRALIA; CONTROLLED STUDY; DIPHTHERIA; HOSPITAL PATIENT; HUMAN; IMMUNIZATION; IMMUNOGENICITY; INFANT; MAJOR CLINICAL STUDY; OUTPATIENT; PERTUSSIS; PRIORITY JOURNAL; TETANUS; VACCINATION;

EID: 0029908807     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1754.1996.tb00933.x     Document Type: Article

References (27)

1. National Health and Medical Research Council. The Australian Immunization Procedures Handbook, 5th edn. Australian Government Publishing Service, Canberra, 1994.
2. Bernstein H, Rothstein E, Pennridge Pediatrics et al. Comparison of 3-component acellular pertussis vaccine (DTaP) with whole-cell pertussis vaccines (DTwP) as a primary series. Pediatr. Res. 1994; 35: 174A.
3. Meade BD, Edwards KM, Decker MD et al. Multicenter trial of 13 acellular pertussis vaccines: analysis of the serologic response. Biologicals 1993; 21: 6-7.
4. Schmitt HJ, Wagner S. Pertussis vaccines - 1993. Eur. J. Pediatr. 1993; 152: 462-6.
5. Harris G, Nolan TM, Hartman L. Clinical signs associated with Triple Antigen (DTP) vaccination in infants. J. Paediatr. Child Health 1994; 31: 228-32.
6. Aggerbeck H, Heron I. Improvement of a vero cell assay to determine diphtheria antitoxin content in sera. Biologicals 1991; 19: 71-6.
7. Cox JG, Premier R, Finger W, Hurrell JGR. A comparison of enzyme immunosassay and bioassay for the quantitative determination of antibodies to tetanus toxin. J. Biol. Standardization 1983; 11: 123-8.
8. Ozutsumi K, Sugimoto N, Matsuda M. Rapid simplified method for production and purification of tetanus toxin. App. Env. Micro. 1985; 49: 939-43.
9. Bennet J, Drane D, Pietrzykowski E, Stefancic A, Seddon F, Cox J. The development and validation of antigen and antibody assays for B. pertussis. Biologicals 1993; 21: 43.
10. Manclark CR, Burstyn DG. Serological response to Bordetella pertussis. In: Rose NR, Friedman H, Fahey JL, eds. Manual of Clinical Laboratory Immunology. American Society of Microbiology, Washington DC, 1986; 338-94.
11. Mortimer EA. Diphtheria toxoid. In Plotkin SA, Mortimer EA, eds. Vaccines, 2nd edn. WB Saunders, Philadelphia, 1994; 41-56.
12. Wassilak SGF, Orenstein WA, Sutter RW. Tetanus toxoid. In Plotkin SA, Mortimer EA, eds. Vaccines, 2nd edn. WB Saunders, Philadelphia, 1994; 57-90.
13. Baker JD, Halperin SA, Edwards K, Miller B, Decker M, Stephens D. Antibody response to Bordetella pertussis antigens after immunization with American and Canadian whole-cell vaccines. J. Pediatr. 1992; 121: 523-7.
14. Preston NW, Carter EJ. Serotype specificity of vaccine-induced immunity to pertussis. Communicable Dis. Report 1992; 2: R155-6.
15. Preston NW. Pertussis vaccination: Neither panic nor complacency. Lancet 1994; 344: 491-2.
16. Granstrom M, Granstrom G. Serological correlates in whooping cough. Vaccine 1993; 11: 445-8.
17. Booy R, Aitken SJM, Taylor S et al. Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3 and 4 months versus 3, 5, and 9 months of age. Lancet 1992; 339: 507-10.
18. Cutts FT, Begg N. Diphtheria, pertussis, and tetanus vaccination (letter). Lancet 1992; 339: 1355-6.
19. Preston NW. Diphtheria, pertussis, and tetanus vaccination. Lancet 1992; 339: 1356.
20. Herceg A, Mead C, Passaris I, Gordon A. Bordetella pertussis in an ACT school: Outbreak investigation and vaccine efficacy study. Communicable Dis. Intelligence 1993; 17: 284-6.
21. Maclntyre R, Hogg G. Surveillance for Bordetella pertussis infection in Victoria. Aust. J. Public Health 1994; 18: 21-4.
22. Bass JW, Wittier RR. Return of epidemic pertussis in the United States. Pediatr. Infect. Dis. J. 1994; 13: 43-5.
23. Australian Bureau of Statistics. 1989-90 National Health Survey Children's Immunization, Australia-Catalogue No. 4379.0. Australian Bureau of Statistics, Canberra, 1992; 1-8.
24. Lester R, Nolan TM. Unacceptably high rates of immunization with DT instead of DTP. Med. J. Aust. 1993; 159: 631.
25. Macintyre CR, Nolan TM. Attitudes of Victorian vaccine providers to pertussis vaccine. Med. J. Aust. 1994; 161: 295-9.
26. Miller E, Ashworth LAE, Robinson A, Waight PA, Irons LI. Phase II trial of whole-cell pertussis vaccine vs an acellular vaccine containing agglutinogens. Lancet 1991; 337: 70-3.
27. Edwards KM, Decker MD, Steinhoff MC et al. Comparison of 13 acellular pertussis vaccines: Adverse reactions. Biologicals 1993; 21: 8-9.